Sana Biotechnology, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Sana Biotechnology, Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $89.75M.
- Sana Biotechnology, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $180.01M.
- Sana Biotechnology, Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $27.25M.
- Sana Biotechnology, Inc. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $724.00K.
- Sana Biotechnology, Inc. stock issued during period, value, new issues for fiscal 2024 was $180.01M.
- Sana Biotechnology, Inc. stock issued during period, value, new issues for fiscal 2021 was $626.40M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $89.75M 10-Q · filed 2026-08-10 | |
| 2024-12-31 | $180.01M 10-K · filed 2025-03-17 | |
| 2024-03-31 | $180.01M 10-Q · filed 2025-05-08 | |
| 2023-06-30 | $27.25M 10-Q · filed 2023-11-08 | |
| 2022-09-30 | $724.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $626.40M 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |